PITTSBURGH, Sept. 6, 2022 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS), a worldwide pharmaceutical firm, at the moment introduced the corporate will take part within the BofA World Analysis World Healthcare Convention in London on Thursday, September 15, 2022. Chief Government Officer Michael Goettler, President Rajiv Malik and Chief Monetary Officer Sanjeev Narula will symbolize the corporate in a hearth chat scheduled at 4:45 p.m. BST / 11:45 a.m. ET.
events can entry a dwell webcast of the occasion at investor.viatris.com. An archived model additionally can be obtainable following the dwell occasion and could be accessed on the similar location for a restricted time.
About Viatris
Viatris Inc. (NASDAQ: VTRS), is a worldwide pharmaceutical firm empowering folks worldwide to dwell more healthy at each stage of life. We offer entry to medicines, advance sustainable operations, develop modern options and leverage our collective experience to attach extra folks to extra services by means of our one-of-a-kind World Healthcare Gateway®. Fashioned in November 2020, Viatris brings collectively scientific, manufacturing and distribution experience with confirmed regulatory, medical, and business capabilities to ship high-quality medicines to sufferers in additional than 165 international locations and territories. Viatris’ portfolio includes greater than 1,400 authorised molecules throughout a variety of therapeutic areas, spanning each non-communicable and infectious ailments, together with globally acknowledged manufacturers, complicated generic and branded medicines, a portfolio of biosimilars and quite a lot of over-the-counter client merchandise. With roughly 37,000 colleagues globally, Viatris is headquartered within the U.S., with world facilities in Pittsburgh, Shanghai and Hyderabad, India. Be taught extra at viatris.com and investor.viatris.com, and join with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
SOURCE Viatris Inc.
For additional info: MEDIA, +1.724.514.1968, [email protected]; Jennifer Mauer, [email protected]; Matt Klein, [email protected]; INVESTORS: +1.724.514.1813, [email protected]; Invoice Szablewski, [email protected]
